Approval · Notice of Compliance 2636 · 2001
PROTOPIC: Notice of Compliance 2636
Issued June 25, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2636
- Date
- June 25, 2001
- Company
- Fujisawa Canada Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical immunomodulator
Products in this notice
Medicinal ingredients
- TACROLIMUS 0.03 PER
- TACROLIMUS 0.1 PER